Publication:
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

Simple item page
dc.contributor.authorRodríguez-Baño, Jesús
dc.contributor.authorRossolini, Gian Maria
dc.contributor.authorSchultsz, Constance
dc.contributor.authorTacconelli, Evelina
dc.contributor.authorMurthy, Srinivas
dc.contributor.authorOhmagari, Norio
dc.contributor.authorHolmes, Alison
dc.contributor.authorBachmann, Till
dc.contributor.authorGoossens, Herman
dc.contributor.authorCanton, Rafael
dc.contributor.authorRoberts, Adam P.
dc.contributor.authorHenriques-Normark, Birgitta
dc.contributor.authorClancy, Cornelius J.
dc.contributor.authorHuttner, Benedikt
dc.contributor.authorFagerstedt, Patriq
dc.contributor.authorLahiri, Shawon
dc.contributor.authorKaushic, Charu
dc.contributor.authorHoffman, Steven J.
dc.contributor.authorWarren, Margo
dc.contributor.authorZoubiane, Ghada
dc.contributor.authorEssack, Sabiha
dc.contributor.authorLaxminarayan, Ramanan
dc.contributor.authorPlant, Laura
dc.contributor.authoraffiliation[Rodríguez-Baño,J] Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain. [Rodríguez-Baño,J] Departamento de Medicina, Universidad de Sevilla, Seville, Spain. [Rodríguez-Baño,J] Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Rossolini,GM] Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. [Rossolini,GM] Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy. [Schultsz,C] Department of Global Health–AIGHD Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Tacconelli,E] Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy. [Murthy,S] BC Children’s Hospital, University of British Columbia, Vancouver, Canada. [Ohmagari,N] Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. [Holmes,A] Department of Medicine, Faculty of Medicine, Imperial College London, London, UK. [Bachmann,T] The University of Edinburgh, Edinburgh Medical School, Division of Infection and Pathway Medicine, The Chancellor’s Building, Edinburgh, UK. [Goossens,H] Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. [Canton,R] Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain. [Canton,R] Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Roberts,AP] Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK. [Henriques-Normark,B] Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. [Henriques-Normark,B] Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. [Clancy,CJ] University of Pittsburgh, Pittsburgh, PA, USA. [Huttner,B] Division of Infectious Diseases, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland. [Fagerstedt,P; Lahiri,S] JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden. [Kaushic,C; Plant,L] Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada. [Kaushic,C] McMaster Immunology Research Center, Department Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. [Hoffman,SJ] Global Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health and Osgoode Hall Law School, York University, Toronto, Canada. [Warren,M] Access to Medicine Foundation, Amsterdam, The Netherlands. [Zoubiane,G; Essack,S] International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark. [Essack,S] Antimicrobial Research Unit, University of KwaZulu-Natal, Durban, South Africa. [Laxminarayan,R] Center for Disease Dynamics, Economics & Policy, New Delhi, India. [Rodríguez-Baño,J] Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III. Madrid, Spain.
dc.contributor.funderAPR would like to acknowledge funding from the AMR CrossCouncil Initiative through a grant from the Medical Research Council, a Council of UK Research and Innovation [grant number MR/S004793/1], the National Institute for Health Research [grant number NIHR200632] and the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via the Medical Research Council in the UK [grant number MR/S037640/1]. JRB and RC acknowledge funding on AMR from Plan Nacional de I+D+i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/0001 and RD16/0016/ 0011], co-financed by the European Regional Development Fund ‘A way to achieve Europe’, Operative Program Intelligence Growth 2014–2020. JRB also acknowledges the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via Instituto de Salud Carlos III [grant number AC16/00076]. ET acknowledges funding on AMR from the Joint Programming Initiative for Antimicrobial Resistance (JPIAMR) via the German Federal Ministry of Education and Research (BMBF) [grant number 01KI1830], Innovative Medicines Initiative 1 and 2 Joint Undertaking [grants number 115737,115523 and820755] and the Global Antibiotic Research and Development Partnership (GARDP). LP, PF and SL would like to acknowledge funding to the JPIAMR from the European Commission (EXEDRA, JPI-EC-AMR and JPIAMR-ACTION).
dc.date.accessioned2022-10-05T12:44:16Z
dc.date.available2022-10-05T12:44:16Z
dc.date.issued2021-03-01
dc.description.abstractAntimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.es_ES
dc.description.versionYeses_ES
dc.identifier.citationRodríguez-Baño J, Rossolini GM, Schultsz C, Tacconelli E, Murthy S, Ohmagari, et al. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Glob Antimicrob Resist. 2021 Jun;25:5-7es_ES
dc.identifier.doi10.1016/j.jgar.2021.02.013es_ES
dc.identifier.essn2213-7173
dc.identifier.issn2213-7165
dc.identifier.pmcPMC7919515
dc.identifier.pmid33662647es_ES
dc.identifier.urihttp://hdl.handle.net/10668/4234
dc.journal.titleJournal of Global Antimicrobial Resistance
dc.language.isoen
dc.page.number3 p.
dc.publisherElsevier Ltd on behalf of International Society for Antimicrobial Chemotherapyes_ES
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S221371652100045X?via%3Dihubes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAntimicrobial resistancees_ES
dc.subjectCOVID-19es_ES
dc.subjectStewardshipes_ES
dc.subjectSurveillancees_ES
dc.subjectResearches_ES
dc.subjectPandemices_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectAntimicrobial stewardshipes_ES
dc.subjectInfecciones por coronaviruses_ES
dc.subjectInvestigaciónes_ES
dc.subjectPandemiaes_ES
dc.subjectProgramas de optimización del uso de los antimicrobianoses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agentses_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreaks::Epidemics::Pandemicses_ES
dc.subject.meshMedical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infectionses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacteriales_ES
dc.subject.meshMedical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Public Health::Epidemiologyes_ES
dc.subject.meshMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Epidemiologic Methods::Data Collection::Health Surveys::Population Surveillance::Public Health Surveillancees_ES
dc.titleAntimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemices_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
RodriguezBaño_Antimicrobial.pdf
Size:
247.61 KB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
Download

Collections

SAS - Hospital Universitario Virgen Macarena
Instituto de Investigación Biomédica de Sevilla (IBIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía